StockMacro
Menu

Fennec Pharmaceuticals

FENC on XNAS, Fennec Pharmaceuticals Inc.

Measures activity, not value. Not investment advice.

Shares sold short (30 Oct 2026)

454K

-6.8% vs the report before

Short interest, % of shares outstanding

1.3%

35.3M shares outstanding (10 Nov 2026)

Days to cover

3.9

short interest / daily volume

Short sale volume share (20 Nov 2026)

28%

1-year median 37%

Sharp changes

8

short interest spike

Window
454K shares sold short on 30 Oct 2026, 1.3% of shares outstanding, 3.9 days to cover

FINRA short interest by settlement date (the 15th and the last business day of each month). FINRA publishes each report 7 business days after its settlement date. Dashed: 3-year median.

See the numbers
30 Oct 2026: 454K shares sold short, 3.9 days to cover
15 Oct 2026: 488K shares sold short, 3.8 days to cover
30 Sep 2026: 513K shares sold short, 3.9 days to cover
15 Sep 2026: 545K shares sold short, 2.1 days to cover
31 Aug 2026: 521K shares sold short, 2.0 days to cover
14 Aug 2026: 532K shares sold short, 2.2 days to cover
31 Jul 2026: 616K shares sold short, 5.3 days to cover
15 Jul 2026: 609K shares sold short, 3.3 days to cover
30 Jun 2026: 489K shares sold short, 1.3 days to cover
15 Jun 2026: 451K shares sold short, 2.0 days to cover
29 May 2026: 498K shares sold short, 1.4 days to cover
15 May 2026: 623K shares sold short, 1.6 days to cover
30 Apr 2026: 1.1M shares sold short, 9.0 days to cover
15 Apr 2026: 931K shares sold short, 5.2 days to cover
31 Mar 2026: 913K shares sold short, 3.0 days to cover
13 Mar 2026: 807K shares sold short, 6.4 days to cover
27 Feb 2026: 824K shares sold short, 7.1 days to cover
13 Feb 2026: 812K shares sold short, 7.7 days to cover
30 Jan 2026: 770K shares sold short, 8.2 days to cover
15 Jan 2026: 742K shares sold short, 5.5 days to cover
31 Dec 2025: 778K shares sold short, 3.7 days to cover
15 Dec 2025: 859K shares sold short, 5.7 days to cover
28 Nov 2025: 882K shares sold short, 4.0 days to cover
14 Nov 2025: 1.1M shares sold short, 7.3 days to cover
31 Oct 2025: 981K shares sold short, 13.6 days to cover
15 Oct 2025: 1.3M shares sold short, 17.7 days to cover
30 Sep 2025: 1.3M shares sold short, 11.6 days to cover
15 Sep 2025: 1.3M shares sold short, 27.7 days to cover
29 Aug 2025: 1.2M shares sold short, 19.7 days to cover
15 Aug 2025: 1.3M shares sold short, 18.8 days to cover
31 Jul 2025: 1.3M shares sold short, 28.2 days to cover
15 Jul 2025: 1.3M shares sold short, 18.8 days to cover
30 Jun 2025: 1.3M shares sold short, 15.6 days to cover
13 Jun 2025: 1.4M shares sold short, 16.4 days to cover
30 May 2025: 1.4M shares sold short, 9.8 days to cover
15 May 2025: 1.5M shares sold short, 24.1 days to cover
30 Apr 2025: 1.5M shares sold short, 33.6 days to cover
15 Apr 2025: 1.4M shares sold short, 14.4 days to cover
31 Mar 2025: 1.5M shares sold short, 15.2 days to cover
14 Mar 2025: 1.4M shares sold short, 10.5 days to cover
28 Feb 2025: 1.9M shares sold short, 48.3 days to cover
14 Feb 2025: 2.0M shares sold short, 39.7 days to cover
31 Jan 2025: 2.0M shares sold short, 32.9 days to cover
15 Jan 2025: 2.0M shares sold short, 31.1 days to cover
31 Dec 2024: 2.0M shares sold short, 22.6 days to cover
13 Dec 2024: 2.1M shares sold short, 14.4 days to cover
29 Nov 2024: 2.1M shares sold short, 10.2 days to cover
15 Nov 2024: 1.9M shares sold short, 14.0 days to cover
31 Oct 2024: 1.8M shares sold short, 21.2 days to cover
15 Oct 2024: 1.8M shares sold short, 29.0 days to cover
30 Sep 2024: 1.8M shares sold short, 18.1 days to cover
13 Sep 2024: 1.8M shares sold short, 24.6 days to cover
30 Aug 2024: 1.8M shares sold short, 20.9 days to cover
15 Aug 2024: 1.9M shares sold short, 18.7 days to cover
31 Jul 2024: 1.9M shares sold short, 29.6 days to cover
15 Jul 2024: 2.0M shares sold short, 27.9 days to cover
28 Jun 2024: 1.8M shares sold short, 10.4 days to cover
14 Jun 2024: 1.8M shares sold short, 17.8 days to cover
31 May 2024: 1.8M shares sold short, 9.9 days to cover
15 May 2024: 1.7M shares sold short, 7.5 days to cover

What the numbers say

  • 454K shares sold short on 30 Oct 2026, 1.3% of shares outstanding, 3.9 days to cover; -6.8% on the report before (published by FINRA on 10 Nov 2026).

Every measure from this source

Short interest is a position, reported twice a month. Short sale volume is a different measure: the share of each day's trading on off-exchange venues that was a short sale. Market makers sell short routinely, so 40% to 50% is normal.

Days to cover. 3.9 days in the report of 30 Oct 2026, 7.3 a year earlier.
Short interest, % of shares outstanding. 1.3% in the report of 30 Oct 2026, 3.8% a year earlier.
Daily short sale volume share on off-exchange venues. 28% of the off-exchange volume on 20 Nov 2026 was a short sale; its median of the last 12 months 37%. This is a daily flow, not short interest.

Sharp changes

8 in all loaded history, strongest first

Fennec Pharmaceuticals had 1.4M shares sold short in the 15 Sep 2020 report, 8.7× the same report last year.

Short interest spike, became public on 25 Sep 2020

Same report last year: 160K; its normal report is 541K.

See the evidence
This period
1.4M (the 15 Sep 2020 report)
Normal report (median of 24 earlier)
541K
Typical spread (median absolute deviation)
131K
How far from its usual level
+4.3
Same report last year
160K
History used
991 days
2019-09-13: 160K2019-09-30: 154K2019-10-15: 343K2019-10-31: 386K2019-11-15: 423K2019-11-29: 419K2019-12-13: 425K2019-12-31: 469K2020-01-15: 499K2020-01-31: 485K2020-02-14: 559K2020-02-28: 670K2020-03-13: 667K2020-03-31: 853K2020-04-15: 691K2020-04-30: 674K2020-05-15: 534K2020-05-29: 548K2020-06-15: 514K2020-06-30: 1.4M2020-07-15: 1.2M2020-07-31: 1.1M2020-08-14: 1.1M2020-08-31: 1.2M2020-09-15: 1.4M
the 15 Sep 2020 report24 earlier reportsnormal: 541K

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

Check it at the source: FINRA short interest data.

Fennec Pharmaceuticals had 1.4M shares sold short in the 30 Sep 2020 report, 9.1× the same report last year.

Short interest spike, became public on 10 Oct 2020

Same report last year: 154K; its normal report is 554K.

See the evidence
This period
1.4M (the 30 Sep 2020 report)
Normal report (median of 24 earlier)
554K
Typical spread (median absolute deviation)
133K
How far from its usual level
+4.3
Same report last year
154K
History used
1,006 days
2019-09-30: 154K2019-10-15: 343K2019-10-31: 386K2019-11-15: 423K2019-11-29: 419K2019-12-13: 425K2019-12-31: 469K2020-01-15: 499K2020-01-31: 485K2020-02-14: 559K2020-02-28: 670K2020-03-13: 667K2020-03-31: 853K2020-04-15: 691K2020-04-30: 674K2020-05-15: 534K2020-05-29: 548K2020-06-15: 514K2020-06-30: 1.4M2020-07-15: 1.2M2020-07-31: 1.1M2020-08-14: 1.1M2020-08-31: 1.2M2020-09-15: 1.4M2020-09-30: 1.4M
the 30 Sep 2020 report24 earlier reportsnormal: 554K

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

Check it at the source: FINRA short interest data.

Fennec Pharmaceuticals had 900K shares sold short in the 31 Jan 2023 report, 3.1× the same report last year.

Short interest spike, became public on 10 Feb 2023

Same report last year: 291K; its normal report is 295K.

See the evidence
This period
900K (the 31 Jan 2023 report)
Normal report (median of 24 earlier)
295K
Typical spread (median absolute deviation)
98K
How far from its usual level
+4.2
Same report last year
291K
History used
1,859 days
2022-01-31: 291K2022-02-15: 299K2022-02-28: 282K2022-03-15: 280K2022-03-31: 271K2022-04-14: 270K2022-04-29: 265K2022-05-13: 265K2022-05-31: 258K2022-06-15: 211K2022-06-30: 158K2022-07-15: 155K2022-07-29: 184K2022-08-15: 303K2022-08-31: 352K2022-09-15: 492K2022-09-30: 498K2022-10-14: 466K2022-10-31: 547K2022-11-15: 588K2022-11-30: 611K2022-12-15: 577K2022-12-30: 657K2023-01-13: 701K2023-01-31: 900K
the 31 Jan 2023 report24 earlier reportsnormal: 295K

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

Check it at the source: FINRA short interest data.

Fennec Pharmaceuticals had 657K shares sold short in the 30 Dec 2022 report, 1.8× the same report last year.

Short interest spike, became public on 12 Jan 2023

Same report last year: 360K; its normal report is 295K.

See the evidence
This period
657K (the 30 Dec 2022 report)
Normal report (median of 24 earlier)
295K
Typical spread (median absolute deviation)
61K
How far from its usual level
+4.0
Same report last year
360K
History used
1,827 days
2021-12-15: 360K2022-01-14: 315K2022-01-31: 291K2022-02-15: 299K2022-02-28: 282K2022-03-15: 280K2022-03-31: 271K2022-04-14: 270K2022-04-29: 265K2022-05-13: 265K2022-05-31: 258K2022-06-15: 211K2022-06-30: 158K2022-07-15: 155K2022-07-29: 184K2022-08-15: 303K2022-08-31: 352K2022-09-15: 492K2022-09-30: 498K2022-10-14: 466K2022-10-31: 547K2022-11-15: 588K2022-11-30: 611K2022-12-15: 577K2022-12-30: 657K
the 30 Dec 2022 report24 earlier reportsnormal: 295K

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

Check it at the source: FINRA short interest data.

Fennec Pharmaceuticals had 701K shares sold short in the 13 Jan 2023 report, 2.2× the same report last year.

Short interest spike, became public on 26 Jan 2023

Same report last year: 315K; its normal report is 295K.

See the evidence
This period
701K (the 13 Jan 2023 report)
Normal report (median of 24 earlier)
295K
Typical spread (median absolute deviation)
70K
How far from its usual level
+3.9
Same report last year
315K
History used
1,841 days
2022-01-14: 315K2022-01-31: 291K2022-02-15: 299K2022-02-28: 282K2022-03-15: 280K2022-03-31: 271K2022-04-14: 270K2022-04-29: 265K2022-05-13: 265K2022-05-31: 258K2022-06-15: 211K2022-06-30: 158K2022-07-15: 155K2022-07-29: 184K2022-08-15: 303K2022-08-31: 352K2022-09-15: 492K2022-09-30: 498K2022-10-14: 466K2022-10-31: 547K2022-11-15: 588K2022-11-30: 611K2022-12-15: 577K2022-12-30: 657K2023-01-13: 701K
the 13 Jan 2023 report24 earlier reportsnormal: 295K

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

Check it at the source: FINRA short interest data.

Fennec Pharmaceuticals had 1.0M shares sold short in the 15 Feb 2023 report, 3.4× the same report last year.

Short interest spike, became public on 28 Feb 2023

Same report last year: 299K; its normal report is 301K.

See the evidence
This period
1.0M (the 15 Feb 2023 report)
Normal report (median of 24 earlier)
301K
Typical spread (median absolute deviation)
130K
How far from its usual level
+3.7
Same report last year
299K
History used
1,874 days
2022-02-15: 299K2022-02-28: 282K2022-03-15: 280K2022-03-31: 271K2022-04-14: 270K2022-04-29: 265K2022-05-13: 265K2022-05-31: 258K2022-06-15: 211K2022-06-30: 158K2022-07-15: 155K2022-07-29: 184K2022-08-15: 303K2022-08-31: 352K2022-09-15: 492K2022-09-30: 498K2022-10-14: 466K2022-10-31: 547K2022-11-15: 588K2022-11-30: 611K2022-12-15: 577K2022-12-30: 657K2023-01-13: 701K2023-01-31: 900K2023-02-15: 1.0M
the 15 Feb 2023 report24 earlier reportsnormal: 301K

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

Check it at the source: FINRA short interest data.